TSMHT
CLBT icon

Thurston Springer Miller Herd & Titak’s Cellebrite CLBT Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.46K Hold
511
– – ﹤0.01% 905
2026
Q1 		$7.04K Hold
511
– – ﹤0.01% 982
2025
Q4 		$9.21K Buy
+511
New +$9.18K ﹤0.01% 982

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's CLBT Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Cellebrite (CLBT) position steady in Q2 2026 at 511 shares worth $7.46K. The position accounts for ﹤0.01% of the portfolio, ranked #905.

Thurston Springer Miller Herd & Titak first reported a position in CLBT in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.21K in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 511 shares of Cellebrite worth $7.46K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #905 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Cellebrite in Q4 2025 and has held it in 3 quarters since.
  • Thurston Springer Miller Herd & Titak's Cellebrite position peaked at $9.21K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.